Thursday, April 06, 2017 7:35:26 PM
http://s1.q4cdn.com/460208960/files/News/2017/April-4-2017_CASI_Zeng.pdf
A Zachs PR titled "CASI Exited Fiscal 2016 with a Strong Balance Sheet" came out the same day. Funny how CASI tanked today w everything going good as it looks like if one read the Analyst report. Just goes to show you that until CASI starts making money it's at the mercy of money managers. Anyhows, it talks of when Evomela, Marqibo, and Zevalin will be approved in China as well as what's going on w CASIs drug ENMD-2076 prospects in FLC. Definitely worth reading.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM